Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|June 3, 2016
Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysisEilon Krashin, Osnat J Dolberg, Ilana Hellmann, et al.
Annals of Hematology|September 13, 2019
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control studyTamar Berger, Uri Rozovski, Yakir Moshe, et al.
European Journal of Haematology|September 19, 2020
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remissionYishai Ofran, Ronit Leiba, Avraham Frisch, et al.
American Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
Blood Advances|December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort studyOfir Wolach, Itai Levi, Boaz Nachmias, et al.
American Journal of Hematology|January 25, 2013
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter studyDrorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndromeYishai Ofran, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Pageof 1